Preliminary safety, PK/PD, and antitumor activity of XmAb18087, an SSTR2 x CD3 bispecific antibody, in patients with advanced neuroendocrine tumors Meeting Abstract
| Authors: | El-Rayes, B.; Pant, S.; Villalobos, V.; Hendifar, A.; Chow, W.; Konda, B.; Reilley, M.; Benson, A.; Fisher, G.; Starr, J.; Strosberg, J.; Ahn, D.; Perez, K.; Raj, N.; Eads, J.; Hobday, T.; Chollate, S.; Ding, Y.; Fleener, C.; Shorr, J. |
| Abstract Title: | Preliminary safety, PK/PD, and antitumor activity of XmAb18087, an SSTR2 x CD3 bispecific antibody, in patients with advanced neuroendocrine tumors |
| Meeting Title: | 13th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society (NANETS2020) |
| Journal Title: | Pancreas |
| Volume: | 50 |
| Issue: | 3 |
| Meeting Dates: | 2020 Oct 2-3 |
| Meeting Location: | Virtual |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2021-03-01 |
| Start Page: | 445 |
| End Page: | 446 |
| Language: | English |
| ACCESSION: | WOS:000655285500054 |
| PROVIDER: | wos |
| PUBMED: | 33835977 |
| DOI: | 10.1097/MPA.0000000000001763 |
| Notes: | Meeting Abstract: C-1 -- Source: Wos |
